Onkydra: a rare-cancer perturbation lab

The problem they're solving

In-silico target validation for rare cancer: pick a real tumour state, compare the interventions, leave with a bench-ready experiment. Every number sourced, every caveat in view. Research use only.

Category · Professional Services Access